在阿曼因COVID-19住院后症状的持续性:双向观测研究
Issa Al Jahdhami1, Husna Arshad1, Hiba Omar2
1Department of Medicine, Armed Forces Hospital, Muscat, Oman.
Oman medical journal
|January 29, 2024
概括
在COVID-19后持续的症状很常见,影响近40%的患者. 这些COVID-19后的症状,包括咳和呼吸困难,在那些有潜在健康状况和严重初始疾病的人中更为普遍.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 公共卫生 公共卫生
背景情况:
- 后COVID-19综合征,以持续的症状为特征,在SARS-CoV-2感染后影响了大量个人.
- 了解这些长期影响的流行率和预测因素对于患者管理和医疗保健规划至关重要.
研究的目的:
- 评估在患有轻度,重度和危急疾病的患者中持续的COVID-19相关症状的患病率.
- 为了确定COVID-19后综合征的预测因素.
主要方法:
- 进行了一项双向队列观察研究.
- 成年患者 (≥18岁) 患有COVID-19感染,从2020年7月至2022年6月活着出院,在出院后6周和12周进行了随访.
- 数据收集包括问卷,胸部X射线和血液测试;健康护理人员也参与了轻度感染.
主要成果:
- 在468名参与者中,39.7%的人报告了咳和呼吸困难等残留症状.
- 伴随性疾病 (高血压,糖尿病,脂质失调) 和轻度疾病患者的症状更为常见.
- 在21名患者中观察到COVID-19后的肺纤维化,主要是那些患有需要重症监护或长时间住院治疗的严重疾病的人.
结论:
- 持续症状和后COVID-19综合征在出院后两个月普遍存在,特别是在患有严重急性COVID-19的患者中.
- 后COVID-19综合征的预测因素包括女性性别,年龄较大,并发症,疾病严重程度和高血压.
- 这些患者群体需要彻底评估和长期跟踪症状管理.
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Pneumonia II: Pathophysiology
274
The pathophysiology of pneumonia involves the following steps:
274
Pleural Effusion II: Symptoms and Management
176
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
176
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Pneumonia IV: Management
329
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
329


